ArticleFrontiers in public health2025
Global, regional and national burden of drug use disorders, 1990-2021: decomposition analysis, health inequality analysis and predictions to 2035.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global substance use disorders burden from 1990 to 2021: post-COVID shifts and widening inequalities.Journal of global health · 2026Article
- Global burden and forecast of infectious diseases attributable to drug use: evidence from GBD 2021.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Drug use disorders (DUDs), a significant public health issue worldwide, encompass disorders related to sedatives, cannabis, opioids, heroin, hallucinogens, club drugs, and inhalants. This study examines the changes in the global burden of DUDs from 1990 to 2021, aiming to provide a scientific foundation for strategies to mitigate the harms associated with substance abuse. Methods: The study utilized Global Burden of Disease (GBD) 2021 data to analyze trends in the incidence, prevalence, mortality, disability-adjusted life years (DALYs) associated with DUDs through Socio-demographic Index (SDI), attributable risk factors, and EAPC. Decomposition analysis was employed to assess the impact of age, gender, and SDI on the burden of DUDs, while the inequality distribution of DALYs was examined using the inequality slope index (SII) and the concentration index (CI). Results: Opioid use disorder accounted for the highest age-standardized disability rates (ASDR) and age-standardized mortality rates (ASMR) among the five drug use disorders, while cannabis use disorder is the leading cause of Age-standardized prevalence rates (ASPR). The Age-standardized incidence rates (ASIR) of opioid use disorder has demonstrated a downward trend, whereas both ASPR and ASMR have shown an increase; notably, the ASIR for opioid use disorder has declined the least among the five drug use disorders. The burden of DUDs in high SDI areas is significantly greater than that in low SDI areas, with income inequality exacerbating the uneven distribution of DALYs. The primary attributable risk factors are drug use and behavioral risks. While the ASIR of opioid use disorder is increasing, while others are experiencing a decline. The burden of DUDs varies among the five drug use disorders due to factors such as population aging, population changes, and age distribution. Conclusion: The findings reveal absolute and relative inequalities in DALYs associated with drug use disorders, which are concentrated in high-income regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.